Worby Colin J, Earl Ashlee M, Turbett Sarah E, Becker Margaret, Rao Sowmya R, Oliver Elizabeth, Taylor Walker Allison, Walters Maroya, Kelly Paul, Leung Daniel T, Knouse Mark, Hagmann Stefan H F, Ryan Edward T, LaRocque Regina C
Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Open Forum Infect Dis. 2020 Dec 21;7(12):ofaa543. doi: 10.1093/ofid/ofaa543. eCollection 2020 Dec.
We performed prospective screening of stool for multidrug-resistant organisms from 608 US international travelers and identified an acquisition rate of 38% following travel. Carriage rates remained significantly elevated for at least 6 months post-travel. Travel-related diarrhea was a risk factor for acquisition, as well as for long-term carriage upon return.
我们对608名美国国际旅行者的粪便进行了耐多药微生物的前瞻性筛查，发现旅行后获得率为38%。旅行后至少6个月内携带率仍显著升高。与旅行相关的腹泻是获得感染的一个危险因素，也是回国后长期携带的危险因素。
